Product Details:


Product Description

MabCampath is used to treat patients with B-cell chronic lymphocytic leukaemia (B-CLL), a cancer of a type of white blood cell called B lymphocytes. MabCampath is used in patients for whom treatment combinations including fludarabine (another medicine used in leukaemia) are not appropriate. The medicine can only be obtained with a prescription.
  • Medicine Name: Mabcampath
  • Generic Name: Alemtuzumab
  • Approval Date: 2001
  • Company Name: Genzyme Corporation
  • Available as (Form & Strength): 30 mg/1 mL single use vial
Enter Buying Requirement Details
Email Id
Mobile number

We Mainly Deal in International Market.
Back to top
trade india member
PRISSM PHARMA All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.